Northwest Biotherapeutics reported 6.96M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US $ 228.38M 19.32M
Applied Genetic Technologies AGTC:US $ 67.85M 4.92M
AstraZeneca AZN:LN 4817M 945M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Celldex Therapeutics CLDX:US $ 28.4M 3.11M
Cti Biopharma CTIC:US $ 66.09M 30.81M
Cytori Therapeutics CYTX:US $ 18.09M 3.15M
Cytrx CYTR:US 5.08M 1.69M
Eisai 4523:JP Y 287815M 23426M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Infinity Pharmaceuticals INFI:US $ 45.84M 7.29M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Northwest Biotherapeutics NWBO:US 6.96M 8.21M